Metraipolis › archive › dc_e9719aed9080
Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound — Europe PMC PMID:41799167
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41799167
- DOI
- 10.5937/jomb0-58742
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T21:08:44.533Z
- SHA-256 of the archived text
166af010e0a6c678703154a8bdceda9e165b5e0a7870be40afe0a31c9e616cb3- Stable URL of this page
https://metraipolis.com/documento/dc_e9719aed9080
How to cite
Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound — Europe PMC PMID:41799167 — Europe PMC (en), https://europepmc.org/article/MED/41799167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9719aed9080 (Metraipolis archive dc_e9719aed9080, sha256 166af010e0a6c678703154a8bdceda9e165b5e0a7870be40afe0a31c9e616cb3)
BibTeX
@misc{dce9719aed9080,
title = {Serum CXCL8 as a biomarker for predicting ALNM in breast cancer: Combined diagnostic value with tumor markers and ultrasound — Europe PMC PMID:41799167},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41799167},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9719aed9080; sha256 166af010e0a6c678703154a8bdceda9e165b5e0a7870be40afe0a31c9e616cb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41799167. Agents can read the archived copy with the MCP tool read_document.